LUNA-18 by Chugai Pharmaceutical for Solid Tumor: Likelihood of Approval

LUNA-18 is under clinical development by Chugai Pharmaceutical and currently in Phase I for Solid Tumor.

May 17, 2024 - 04:00

LUNA-18 is under clinical development by Chugai Pharmaceutical and currently in Phase I for Solid Tumor.

Read the original article

Tags:

Previous Article

LZ-901 by Beijing Luzhu Biotechnology for Herpes Zoster (Shingles): Likelihood o...

Bristol Myers’ Cancer Cell Therapy Receives FDA Green Light

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Risk adjusted net present value: What is the current va...

Jul 2, 2024

AstraZeneca wins approval for Imfinzi in NSCLC perioperative setting

AstraZeneca wins approval for Imfinzi in NSCLC perioper...

Aug 17, 2024

AbbVie’s Elahere wins European approval for certain ovarian cancers

AbbVie’s Elahere wins European approval for certain ova...

Nov 19, 2024